W1132 A 3-Week Course of 80 Mg Weekly Administered Adalimumab As a Rescue Therapy for Patients with Crohn's Disease Who Lost Response to 40 Mg Weekly: Relationship with Adalimumab Trough Serum Levels

Autor:	Paul Rutgeerts, Gert A. Van Assche, Maja Noman, Konstantinos Karmiris, Gilles Paintaud, Danielle Degenne, Marc Ferrante, Severine Vermeire, Anne-Claire Duveau
Rok vydání:	2008
Předmět:	Crohn's disease medicine.medical_specialty Hepatology business.industry Gastroenterology Trough (geology) medicine.disease Surgery Rescue therapy Internal medicine Adalimumab Medicine business medicine.drug
Zdroj:	Gastroenterology. 134:A-640
ISSN:	0016-5085
DOI:	10.1016/s0016-5085(08)62986-8
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::77c72f504bfe7dcd7f1899b4512bb36c https://doi.org/10.1016/s0016-5085(08)62986-8 Zobrazit plný text záznamu